SeaStar Medical Holding Corporation（纳斯达克代码：ICU）近日发布招股说明书补充文件，披露公司一位持股股东计划在适当时机通过二级市场转售其持有的部分普通股股份。
根据文件披露，该股东拟转售的股份数量最高可达200万股。招股书明确说明，此次股份转售属于股东个人行为，公司不会从此次转售中获得任何收益。
此次转售将根据市场情况不定期进行，具体交易时间和数量将视市场条件而定。公司表示，此次招股说明书补充文件的发布旨在确保信息披露的及时性和透明度，让投资者充分了解潜在股份变动情况。
SeaStar Medical Holding Corporation作为一家专注于危重症治疗解决方案的生物技术公司，将继续推进其核心业务发展。公司强调，此次股东股份转售不会影响公司的日常运营和长期发展战略。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.